JPMorgan Chase Cash & Equivalents decreased by 9.1% to $312.14B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.7%, from $425.90B to $312.14B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows a downward trend with a -8.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $705.42B | $759.87B | $740.83B | $754.53B | $669.26B | $644.19B | $567.23B | $546.00B | $495.12B | $511.37B | $624.15B | $562.12B | $530.82B | $434.26B | $469.32B | $425.90B | $420.33B | $303.44B | $343.34B | $312.14B |
| QoQ Change | — | +7.7% | -2.5% | +1.8% | -11.3% | -3.7% | -11.9% | -3.7% | -9.3% | +3.3% | +22.1% | -9.9% | -5.6% | -18.2% | +8.1% | -9.3% | -1.3% | -27.8% | +13.2% | -9.1% |
| YoY Change | — | — | — | — | -5.1% | -15.2% | -23.4% | -27.6% | -26.0% | -20.6% | +10.0% | +3.0% | +7.2% | -15.1% | -24.8% | -24.2% | -20.8% | -30.1% | -26.8% | -26.7% |